MRNA Operating Cash Flow

Moderna · Operating Cash Flow

MRNA logo

MRNA Operating Cash Flow

Latest reported-$526.00M
MRNA Quarterly Operating Cash Flow (-$92.97M → -$526.00M)
High-resolution chart · PNG

MRNA operating cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Moderna Operating Cash Flow — Quarterly (USD)
Period endingOperating Cash Flow (USD)
-526,000,000
-630,000,000
951,000,000
-847,000,000
-919,000,000
-1,037,000,000
825,000,000
-1,566,000,000
-1,274,000,000
-989,000,000
622,000,000
-1,600,000,000
-915,000,000
-1,225,000,000
1,662,000,000
252,000,000
304,000,000
2,763,000,000
3,310,000,000
3,276,000,000
4,063,000,000
2,971,000,000
1,264,289,000
892,748,000
-23,875,000
-106,191,000
-95,773,000
-107,048,000
-112,220,000
-143,927,000
-91,020,000
-80,211,000
-48,249,000
-111,385,000
-102,927,000
-42,620,000
-92,968,500
-92,968,500
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.